Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Drug repositioning for post cardiopulmonary resuscitation syndrome using large-scale medical claims

  • At: Glasgow (Scotland) (2018)
  • Type: Poster
  • Poster code: POS-DDD-008
  • By: ZAMAMI, Yoshito (Tokushima University Graduate School of Biomedical Sciences, Clinical Pharmacology and Therapeutics)
  • Co-author(s): Yoshito Zamami: Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Pharmacy, Tokushima University Hospital, Tokushima, Japan
    Yuki Izawa-Ishizawa: Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Takahiro Niimura: Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Kenshi Takechi: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
    Masaki Imanishi: Pharmacy, Tokushima University Hospital, Tokushima, Japan
    Masayuki Chuma: Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan
    Yuya Horinouchi: Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Yasumasa Ikeda: Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Koichiro Tsuchiya: Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan
    Keisuke Ishizawa: Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan;Pharmacy, Tokushima University Hospital, Tokushima, Japan
  • Abstract:

    Background

    Worldwide, approximately one hundred million people develop cardiac arrest every year, and the survival rate is very low. Therefore, the development of novel drug for post cardiopulmonary resuscitation syndrome is desirable. In recent years, drug repositioning has been proposed as a strategy for developing existing drugs as therapeutic..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses